Experimental & Molecular Medicine · 2012 · 34 citations · 26 references
MedicineCell BiologyEndocrinologyBone MetabolismCalcium HomeostasisMineral MetabolismBone FormationBone HealthOsteoclast BiologyOsteoclast FunctionOxidative Damage To BiomoleculesReactive Oxygen SpeciesCa2+ SignalingEstrogen MetabolismNanoparticlesNf-κb SignalingNfatc1 ActivationNuclear Factor Kappa B SignalingOsteoclast RegulationRankl-mediated Osteoclastogenesis
Platinum nanoparticles (PtNP) exhibit remarkable antioxidant activity. There is growing evidence concerning a positive relationship between oxidative stress and bone loss, suggesting that PtNP could protect against bone loss by modulating oxidative stress. Intragastric administration of PtNP reduced ovariectomy (OVX)- induced bone loss with a decreased level of activity and number of osteoclast (OC) in vivo. PtNP inhibited OC formation by impairing the receptor activator of nuclear factor-κB ligand (RANKL) signaling. This impairment was due to a decreased activation of nuclear factor-κB and a reduced level of nuclear factor in activated T-cells, cytoplasmic 1 (NFAT2). PtNP lowered RANKL-induced long lasting reactive oxygen species as well as intracellular concentrations of Ca(2+) oscillation. Our data clearly highlight the potential of PtNP for the amelioration of bone loss after estrogen deficiency by attenuated OC formation.
26
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Young‐Yun Kong, Hiroki Yoshida, Ildiko Sarosi et al. · Nature · 1999 · 3.4K citations
Medicine, Cell Biology, Immunology +14
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Giulio F. Paciotti, Lonnie D. Myer, David M. Weinreich et al. · Drug Delivery · 2004 · 1.2K citations
Pharmacy, Oncology, Pharmaceutics +17